Your browser doesn't support javascript.
loading
Comparison of procedural outcomes in patients undergoing catheter vs surgical ablation for atrial fibrillation and heart failure with reduced ejection fraction.
Doshi, Rajkumar; Kumar, Ashish; Shariff, Mariam; Adalja, Devina; Patel, Krunalkumar; Patel, Kirtenkumar; Desai, Rupak; Gullapalli, Nageshwara; Vallabhajosyula, Saraschandra.
Affiliation
  • Doshi R; Department of Internal Medicine University of Nevada Reno School of Medicine Reno NV USA.
  • Kumar A; Department of Critical Care Medicine St John's Medical College Hospital Bengaluru India.
  • Shariff M; Department of Critical Care Medicine St John's Medical College Hospital Bengaluru India.
  • Adalja D; Department of Medicine GMERS Gotri Medical College Vadodara India.
  • Patel K; Department of Medicine St Mary Medical Center Langhorn PA USA.
  • Patel K; Department of Cardiology North Shore University Hospital Manhasset NY USA.
  • Desai R; Department of Cardiology Atlanta VA Medical Center Decatur GA USA.
  • Gullapalli N; Department of Internal Medicine University of Nevada Reno School of Medicine Reno NV USA.
  • Vallabhajosyula S; Section of Interventional Cardiology Division of Cardiovascular Medicine Department of Medicine Emory University School of Medicine Atlanta GA USA.
J Arrhythm ; 37(1): 60-69, 2021 Feb.
Article in En | MEDLINE | ID: mdl-33664887
BACKGROUND: There is a lack of research comparing procedural outcomes of surgical ablation (SA) and catheter ablation (CA) among patients with heart failure with reduced ejection fraction (HFrEF) and atrial fibrillation (AF). The main objective was to compare the short-term procedural outcomes of SA and CA in patients with HFrEF. METHODS: We used the national inpatient sample to identify hospitalizations over 18 years with HFrEF hospitalization and AF, and undergoing SA and CA from 2016 to 2017. Furthermore, the clinical outcomes of SA vs CA in AF stratified as nonparoxysmal and paroxysmal were analyzed. RESULTS: A total of 1,770 HFrEF hospitalizations with AF who underwent SA and 1,620 HFrEF hospitalizations with AF who underwent CA were included in the analysis. Hospitalizations with CA had higher baseline comorbidities. The in-hospital mortality among HFrEF with AF undergoing SA as compared with CA was similar (2.8% vs 1.9%, respectively, adjusted P-value 0.09). Hospitalizations with SA had a significantly longer length of hospital stay, a higher percentage of postprocedural, and cardiac complications. In HFrEF hospitalizations with nonparoxysmal AF, SA as compared with CA was associated with a higher percentage of in-hospital mortality (2.4% vs 1%, adjusted P-value <.05), a longer length of stay, a higher cost of treatment, and a higher percentage of cardiac complications. CONCLUSION: CA is associated with lower in-hospital adverse procedural outcomes as compared with SA among HFrEF hospitalizations with AF. Further research with freedom from AF as one of the outcome is needed between two groups for HFrEF.
Key words